C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01)
Patent
CA 2756193
The present invention provides methods for identifying patients at increased risk of developing an adverse neurological event in response to a cancer treatment. Methods also include modifying the treatment regimen of said patent dependent on the presence or absence of biomarkers in the patient.
La présente invention concerne des procédés d'identification de patients présentant un risque accru de développement d'un événement neurologique indésirable en réponse à un traitement anticancéreux. Les procédés comprennent également la modification du régime de traitement dudit patient en fonction de la présence ou de l'absence de marqueurs biologiques chez le patient.
Cohen Nadine
Favis Reyna
Li Qingqin
Ricci Deborah
Sun Yu
Janssen Pharmaceutica Nv
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Biomarkers for assessing peripheral neuropathy response to... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Biomarkers for assessing peripheral neuropathy response to..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biomarkers for assessing peripheral neuropathy response to... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2035096